发明人冯建国,张德明,唐晓军. "Method for the Synthesis of T5RCK09KHV
150586-58-6
Fipamezole [INN]
Fipamezole
JP-1730
4-((2RS)-2-Ethyl-5-fluoroindan-2-yl)-1H-imidazole
UNII-T5RCK09KHV" [P]. 中国发明专利, 专利号 CN 109365307 A, 授权公告日 2023-08-28.
发明人刘建华,胡光,马晓峰. "A Process for Preparing High-Purity T5RCK09KHV
150586-58-6
Fipamezole [INN]
Fipamezole
JP-1730
4-((2RS)-2-Ethyl-5-fluoroindan-2-yl)-1H-imidazole
UNII-T5RCK09KHV" [P]. 中国发明专利, 专利号 CN 116348193 A, 授权公告日 2021-09-02.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Food Chem., 2015, 291, 1533-1557.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Chromatogr. A, 2022, 395, (7), 6401-6406.
Brown R C, Davis S M. "Identification and Structural Characterization of a Novel Degradation Product of T5RCK09KHV
150586-58-6
Fipamezole [INN]
Fipamezole
JP-1730
4-((2RS)-2-Ethyl-5-fluoroindan-2-yl)-1H-imidazole
UNII-T5RCK09KHV Using HRMS and NMR". Sci. Total Environ., 2018, 1057, 3520-3538.
Fischer P, Wagner E. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Chemosphere, 2019, 370, 346-369.